Back to User profile » Prof. Dr. Ding Ma

Papers published by Prof. Dr. Ding Ma:


TMTP1-Modified, Tumor Microenvironment Responsive Nanoparticles Co-Deliver Cisplatin and Paclitaxel Prodrugs for Effective Cervical Cancer Therapy

Jiang G, Wang X, Zhou Y, Zou C, Wang L, Wang W, Zhang D, Xu H, Li J, Li F, Luo D, Ma X, Ma D, Tan S, Wei R, Xi L

International Journal of Nanomedicine 2021, 16:4087-4104

Published Date: 15 June 2021

Disruption of human papillomavirus 16 E6 gene by clustered regularly interspaced short palindromic repeat/Cas system in human cervical cancer cells [Retraction]

Yu L, Wang XL, Zhu D, Ding W, Wang L, Zhang C, Jiang X, Shen H, Liao S, Ma D, Hu Z, Wang H

OncoTargets and Therapy 2017, 10:2835-2836

Published Date: 2 June 2017

Risk model in stage IB1-IIB cervical cancer with positive node after radical hysterectomy

Chen Z, Huang K, Lu Z, Deng S, Xiong J, Huang J, Li X, Tang F, Wang Z, Sun H, Wang L, Zhou S, Wang X, Jia Y, Hu T, Gui J, Wan D, Ma D, Li S, Wang S

OncoTargets and Therapy 2016, 9:3171-3179

Published Date: 27 May 2016

Disruption of human papillomavirus 16 E6 gene by clustered regularly interspaced short palindromic repeat/Cas system in human cervical cancer cells [Corrigendum]

Yu L, Wang XL, Zhu D, Ding WC, Wang LM, Zhang CL, Jiang XH, Shen H, Liao SJ, Ma D, Hu Z, Wang H

OncoTargets and Therapy 2015, 8:365-366

Published Date: 4 February 2015

Disruption of human papillomavirus 16 E6 gene by clustered regularly interspaced short palindromic repeat/Cas system in human cervical cancer cells

Yu L, Wang XL, Zhu D, Ding WC, Wang LM, Zhang CL, Jiang XH, Shen H, Liao SJ, Ma D, Hu Z, Wang H

OncoTargets and Therapy 2015, 8:37-44

Published Date: 22 December 2014